Amgen
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Amgen (AMGN) Business News
Track Amgen in real time with a live news feed covering Amgen stock news, official press releases, company announcements, and an archive of historical Amgen news. ...more
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
Assetmark Inc. Buys 10,886 Shares of Amgen Inc. $AMGN
EVROPSKÁ KOMISE SCHVÁLILA PŘÍPRAVEK UPLIZNA® SPOLEČNOSTI AMGEN PRO GENERALIZOVANOU MYASTENII GRAVIS
First Look: Tech-led selloff, tariff shifts, AI funding boom
Prices, pipelines and patent cliffs: Inside pharma's big reset
Eubel Brady & Suttman Asset Management Inc. Invests $1.25 Million in Amgen Inc. $AMGN
Amgen (AMGN) is a Top-Ranked Momentum Stock: Should You Buy?
Advisors Asset Management Inc. Sells 2,136 Shares of Amgen Inc. $AMGN
Wealthfront Advisers LLC Grows Stock Position in Amgen Inc. $AMGN
Amgen Inc. $AMGN Stock Holdings Reduced by Allegheny Financial Group
Alps Advisors Inc. Has $5.29 Million Stake in Amgen Inc. $AMGN
Assetmark Inc. Buys 10,886 Shares of Amgen Inc. $AMGN
4:02 AM | Saturday | Feb 14, 2026
Assetmark Inc. boosted its stake in shares of Amgen Inc. (NASDAQ: AMGN) by 5.4% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 213,793 shares of the medical research company's stock after acquiring an additional 10,886 shares during the quarter.
Assetmark Inc.'s
Assetmark Inc. Buys 10,886 Shares of Amgen Inc. $AMGN
Defense WorldAssetmark Inc. boosted its stake in shares of Amgen Inc. (NASDAQ: AMGN) by 5.4% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 213,793 shares of the medical research company's stock after acquiring an additional 10,886 shares during the quarter.
Assetmark Inc.'s
EVROPSKÁ KOMISE SCHVÁLILA PŘÍPRAVEK UPLIZNA® SPOLEČNOSTI AMGEN PRO GENERALIZOVANOU MYASTENII GRAVIS
PRNewsWire/PRNewswire/ - Společnost Amgen (NASDAQ: AMGN) dnes oznámila, že Evropská komise (EK) schválila přípravek UPLIZNA (inebilizumab) jako přídavnou léčbu ke
Read full article
First Look: Tech-led selloff, tariff shifts, AI funding boom
GuruFocusStock News Tech slump hits indexes: A broad risk-off move saw Apple (AAPL) and Cisco (CSCO) lead declines, while Applied Materials (AMAT) rallied on upbeat AI t
Read full article
Prices, pipelines and patent cliffs: Inside pharma's big reset
CNBCPharma earnings weren't the main focus for drugmakers this quarter. "2025 was about understanding kind of the rules of the future of the game," McKinsey Senior Partner Greg Graves told CNBC.
Read full article
Eubel Brady & Suttman Asset Management Inc. Invests $1.25 Million in Amgen Inc. $AMGN
Defense WorldEubel Brady and Suttman Asset Management Inc. purchased a new position in shares of Amgen Inc. (NASDAQ: AMGN) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 4,416 shares of the medical research company's stock, valued at approximately $1,246,000. Other hedge funds and
Read full article
Amgen (AMGN) is a Top-Ranked Momentum Stock: Should You Buy?
Zacks Investment ResearchWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read full article
Advisors Asset Management Inc. Sells 2,136 Shares of Amgen Inc. $AMGN
Defense WorldAdvisors Asset Management Inc. lowered its stake in shares of Amgen Inc. (NASDAQ: AMGN) by 1.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 109,990 shares of the medical research company's stock after selling 2,136 shares during
Read full article
Wealthfront Advisers LLC Grows Stock Position in Amgen Inc. $AMGN
Defense WorldWealthfront Advisers LLC boosted its position in Amgen Inc. (NASDAQ: AMGN) by 22.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 70,233 shares of the medical research company's stock after purchasing an additional 12,857 shares during the
Read full article
Amgen Inc. $AMGN Stock Holdings Reduced by Allegheny Financial Group
Defense WorldAllegheny Financial Group cut its position in shares of Amgen Inc. (NASDAQ: AMGN) by 76.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,899 shares of the medical research company's stock after selling 6,112 shares during the period. Allegheny
Read full article
Alps Advisors Inc. Has $5.29 Million Stake in Amgen Inc. $AMGN
Defense WorldAlps Advisors Inc. raised its holdings in Amgen Inc. (NASDAQ: AMGN) by 63.1% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 18,759 shares of the medical research company's stock after buying an additional 7,254 shares during the period.
Alps Advisors Inc.'s holdings